Compile Data Set for Download or QSAR
maximum 50k data
Report error Found 24 Enz. Inhib. hit(s) with all data for entry = 2143
TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355853(4-ethoxy-N-(3-fluoro-4-((5-pyridin-4-yl)pyrrolo[1,...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355876(N-(4-((5-(3-cyanomethylphenyl)pyrrolo[1,2-b]pyrida...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355855(N-(3-fluoro-4-((5-(3-hydroxymethyl)phenyl)pyrrolo[...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355856(4-ethoxy-N-(3-fluoro-4-((5-(3-(2-hydroxypropan-2-y...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355857(4-ethoxy-N-(3-fluoro-4-((5-(3-(1-hydroxyethyl)phen...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355858(N-(3-fluoro-4-((5-(3-(1-hydroxyethyl)phenyl)pyrrol...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355859(4-ethoxy-N-(3-fluoro-4-((5-(pyrimidin-5-yl)pyrrolo...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355860(4-ethoxy-N-(3-fluoro-4-((5-(3-morpholin-4-carbonyl...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355861(4-ethoxy-N-(3-fluoro-4-((5-(3-aminophenyl)pyrrolo[...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355862(N-(4-((5-(3-((dimethylamino)methyl)phenyl)pyrrolo[...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355863(N-(4-((5-(3-((dimethylamino)methyl)phenyl)pyrrolo[...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355864(N-(4-((5-(3-amino-5-cyanophenyl)pyrrolo[1,2-b]pyri...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355865(N-(4-((5-(3-aminomethylphenyl)pyrrolo[1,2-b]pyrida...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355866(N-(4-((5-(3-(ethylamino)phenyl)pyrrolo[1,2-b]pyrid...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355867(N-(4-((5-(2-chloro-5-((dimethylamino)methyl)phenyl...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355868(N-(4-((5-(5-((dimethylamino)methyl)-2-fluorophenyl...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355869(N-(4-((5-(3-((dimethylamino)methyl)-5-fluorophenyl...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355870(N-(4-((5-(3-amino-4-methyl)-5-fluorophenyl)pyrrolo...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355871(N-(4-((5-(3-amino-2-methyl)-5-fluorophenyl)pyrrolo...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355872(N-(3-fluoro-4-((5-(3-((methylamino)methyl)phenyl)p...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355873(N-(4-((5-(3-((ethylamino)methyl)phenyl)pyrrolo[1,2...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355874(N-(4-((5-(3-amino-4-methoxy)-5-fluorophenyl)pyrrol...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355875(N-(4-((5-(5-amino-2-fluoro)-5-fluorophenyl)pyrrolo...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetHepatocyte growth factor receptor(Human)
The Asan Foundation

US Patent
LigandPNGBDBM355854(4-ethoxy-N-(3-fluoro-4-((5-(3-formylphenyl)pyrrolo...)
Affinity DataIC50: <40nMAssay Description:The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent